Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03682822 · ClinicalTrials.gov registry record · NA
Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT03682822: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT03682822 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03682822, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
To compare the duration of preterm induction of labor in women undergoing early vs. late or no artificial rupture of membranes (AROM). Maternal and neonatal outcomes will also be compared between the two groups.
Primary Outcome
The duration of labor begins with administration of the first induction agent (i.e. Cook balloon, Foley catheter, prostaglandins, or oxytocin) and ends with delivery.
Interventions
- PROCEDURE Early Artificial rupture of membranes
- PROCEDURE Delayed Artificial rupture of membranes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-02-24 |
| Phase | NA |
Why NCT03682822 stopped before completion
NCT03682822 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Early Artificial rupture of membranes is the first listed.
NCT03682822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03682822 about?
NCT03682822 is a clinical study titled "Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial". To compare the duration of preterm induction of labor in women undergoing early vs. late or no artificial rupture of membranes (AROM). Maternal and neonatal outcomes will also be compared between the two groups.
What is the current status of trial NCT03682822?
This trial is currently terminated. It is a NA study. The enrollment target is 104 participants. The study started on 2018-11-01. Estimated completion is 2020-02-24.
What interventions are being tested in trial NCT03682822?
The interventions under investigation include: Early Artificial rupture of membranes (PROCEDURE), Delayed Artificial rupture of membranes (PROCEDURE).
Who is sponsoring clinical trial NCT03682822?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03682822's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI